Clinical Trial Update: Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients [NA]

View source ↗

Summary

Johns Hopkins University is recruiting for a clinical trial evaluating prophylaxis with direct-acting antivirals to prevent hepatitis C infection in kidney tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Johns Hopkins University | Conditions: HCV | NA | Status: RECRUITING